Adding topotecan to carboplatin plus paclitaxel, the standard treatment for ovarian cancer, does not improve progression-free survival in patients and leads to greater toxicity, according to a study published online October ...

Medicine & Health - Cancer

Oct 11, 2010 not rated yet 0